Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies–like model

Immunotherapeutic approaches targeting amyloid β (Aβ) protein and tau in Alzheimer’s disease and α-synuclein (α-syn) in Parkinson’s disease are being developed for treating dementia with Lewy bodies. However, it is unknown if single or combined immunotherapies targeting Aβ and/or α-syn may be effective.

Read more…